ARTICLE | Product Development
Roche, Abbott say sample collection differences hampered COVID-19 sensitivity in independent studies
Companies say the sensitivity of their COVID-19 tests have a lot to do with when samples are collected
May 20, 2020 9:31 PM UTC
Roche and Abbott each responded to independent reports that their COVID-19 tests are less sensitive than claimed with additional validation data supporting stronger performance and statements attributing discrepancies to sampling protocols.
Both companies pointed to sample collection time as a key variable, highlighting how emerging understanding of viral and immune kinetics for COVID-19 is shaping the way tests are evaluated and used in real time...